This study evaluates the variation of expression of the neonatal Fc receptor (FcRn) in Natural Killer T Cells Expressing an Invariant T Receptor (iNKT) and monocytes along with the surface expression of Fc gamma type II receptor (RII) and RIII in active or newly diagnosed lupus patients compared to inactive lupus patients.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
FcRn Expression analysis in Circulating iNKT lymphocytes
Timeframe: through study completion, an average of 3 year
FcRn Expression analysis in circulating monocytes
Timeframe: through study completion, an average of 3 year
FcgammaRII Expression analysis in Circulating iNKT lymphocytes
Timeframe: through study completion, an average of 3 year
FcgammaRII Expression analysis in circulating monocytes
Timeframe: through study completion, an average of 3 year
FcgammaRIII Expression analysis in Circulating iNKT lymphocytes
Timeframe: through study completion, an average of 3 year
FcgammaRIII Expression analysis in in circulating monocytes
Timeframe: through study completion, an average of 3 year